StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Oncolytics Biotech's enterprise value was $44.46M on Nov 11, 2026, against $68.36M a year earlier. Over the last 5 years it ranged from $15.61M to $142.06M, with a median of $56.73M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$44.46M-23.8%
2025Dec 31, 2025$58.31M+55.3%
2024Dec 31, 2024$37.55M-46.0%
2023Dec 29, 2023$69.50M+22.5%
2022Dec 30, 2022$56.73M+79.3%
2021Dec 31, 2021$31.64M-23.9%
2020Dec 31, 2020$41.59M-36.7%
2019Dec 31, 2019$65.67M+296.8%
2018Dec 31, 2018$16.55M-71.7%
2017Dec 29, 2017$58.49M+963.0%
2016Dec 30, 2016$5.50M–

More Oncolytics Biotech figures

See a number that looks wrong?